The National Institute for Health Research (NIHR) is the nation’s largest funder of health and care research – the NIHR oversee 15 Clinical Research Networks (CRN) and these CRNs work alongside NHS Trusts, primary care providers and Universities. Each CRN has a dedicated Study Support Service.
The NIHR have a portfolio of research studies that are eligible for consideration for support from the CRN in England. Portfolio status is usually vital to participating NHS Trusts when considering undertaking a proposed study.
Information on the NIHR portfolio is present on the research blog, but at this session our local CRN’s Study Support team will provide you with an opportunity to hear about and discuss the network and the service, and how it could benefit you.
This session is aimed at those planning on conducting clinical research.
It is also designed to raise awareness at BU about the benefits and importance of the NIHR portfolio, so if you’re just interested in learning more, please book on.
The session will take place on Tuesday 10th December at 2:3opm until 4:00pm on Lansdowne Campus.
To register your interest or if you have any queries, please get in touch with Research Ethics.











Geography and Environmental Studies academics – would you like to get more involved in preparing our next REF submission?
Reminder: Recharge Your Research Routine Next Week for World Wellbeing Week
Boost Your Research Toolkit: Digital Confidence & AI Literacy Workshop – Friday 26 June 10am-12pm
BU students’ publishing success
BU presentation at the University of Bristol
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease